Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM5 | P08912 | 1/20 | 0.61 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.61 |
| ▸ | ACHE | P22303 | 1/20 | 0.53 |
| ▸ | OPRL1 | P41146 | 7/20 | 0.49 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.49 |
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 5/20 | 0.44 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | DRD2 | P14416 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24691763 | 0.83 | CHRM5 (0.61) | CHRM5ADRA2CACHEOPRL1OPRM1 | |
| SCHEMBL22462890 | 0.80 | GBA1 (0.40) | CHRM5ADRA2CACHEOPRL1OPRM1 | |
| SCHEMBL11596303 | 0.79 | CHRM5 (0.84) | CHRM5ADRA2CACHEOPRL1OPRM1 | |
| SCHEMBL5376134 | 0.79 | CHRM5 (0.84) | CHRM5ADRA2CACHEOPRL1OPRM1 | |
| SCHEMBL3376754 | 0.79 | CHRM5 (0.61) | CHRM5ADRA2CACHEOPRL1OPRM1 | |
| Hydrochloric Acid SCHEMBL28536617 | 0.79 | GBA1 (0.39) | CHRM5ADRA2CACHEOPRL1OPRM1 | |
| SCHEMBL12536925 | 0.77 | CHRM5 (0.44) | CHRM5ADRA2CACHEOPRL1OPRM1 | |
| SCHEMBL20643257 | 0.77 | CHRM5 (1.00) | CHRM5ADRA2CACHEOPRL1OPRM1 | |
| SCHEMBL19575409 | 0.77 | CHRM5 (1.00) | CHRM5ADRA2CACHEOPRL1OPRM1 | |
| SCHEMBL1515104 | 0.77 | CHRM5 (1.00) | CHRM5ADRA2CACHEOPRL1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10660897-B2 | C5aR antagonists | CHEMOCENTRYX, INC. (US) | 2020-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10660897-B2 | C5aR antagonists | C5AR1, C5AR2, C3AR1 | CHRM5 372/4885ADRA2C 170/4885ACHE 2691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.